Disease progression score estimation from multimodal imaging and microRNA data using supervised variational autoencoders - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles IEEE Journal of Biomedical and Health Informatics Year : 2022

Disease progression score estimation from multimodal imaging and microRNA data using supervised variational autoencoders

Abstract

Frontotemporal dementia and amyotrophic lateral sclerosis are rare neurodegenerative diseases with no effective treatment. The development of biomarkers allowing an accurate assessment of disease progression is crucial for evaluating new therapies. Concretely, neuroimaging and transcriptomic (microRNA) data have been shown useful in tracking their progression. However, no single biomarker can accurately measure progression in these complex diseases. Additionally, large samples are not available for such rare disorders. It is thus essential to develop methods that can model disease progression by combining multiple biomarkers from small samples. In this paper, we propose a new framework for computing a disease progression score (DPS) from cross-sectional multimodal data. Specifically, we introduce a supervised multimodal variational autoencoder that can infer a meaningful latent space, where latent representations are placed along a disease trajectory. A score is computed by orthogonal projections onto this path. We evaluate our framework with multiple synthetic datasets and with a real dataset containing 14 patients, 40 presymptomatic genetic mutation carriers and 37 controls from the PREV-DEMALS study. There is no ground truth for the DPS in real-world scenarios, therefore we use the area under the ROC curve (AUC) as a proxy metric. Results with the synthetic datasets support this choice, since the higher the AUC, the more accurate the predicted simulated DPS. Experiments with the real dataset demonstrate better performance in comparison with stateof-the-art approaches. The proposed framework thus leverages cross-sectional multimodal datasets with small sample sizes to objectively measure disease progression, with potential application in clinical trials.
Fichier principal
Vignette du fichier
kmetzsch2023-IEEE JBHI-postprint.pdf (4.78 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03789357 , version 1 (27-09-2022)

Licence

Identifiers

Cite

Virgilio Kmetzsch, Emmanuelle Becker, Dario Saracino, Daisy Rinaldi, Agnes Camuzat, et al.. Disease progression score estimation from multimodal imaging and microRNA data using supervised variational autoencoders. IEEE Journal of Biomedical and Health Informatics, 2022, 26 (12), pp.1-12. ⟨10.1109/JBHI.2022.3208517⟩. ⟨hal-03789357⟩
145 View
183 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More